These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8609397)

  • 21. Keratinocyte-derived T cell costimulation induces preferential production of IL-2 and IL-4 but not IFN-gamma.
    Goodman RE; Nestle F; Naidu YM; Green JM; Thompson CB; Nickoloff BJ; Turka LA
    J Immunol; 1994 Jun; 152(11):5189-98. PubMed ID: 7910619
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polarization of naive T cells into Th1 or Th2 by distinct cytokine-driven murine dendritic cell populations: implications for immunotherapy.
    Feili-Hariri M; Falkner DH; Morel PA
    J Leukoc Biol; 2005 Sep; 78(3):656-64. PubMed ID: 15961574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IL-12 reverses established antigen-specific tolerance of contact sensitivity by affecting costimulatory molecules B7-1 (CD80) and B7-2 (CD86).
    Ushio H; Tsuji RF; Szczepanik M; Kawamoto K; Matsuda H; Askenase PW
    J Immunol; 1998 Mar; 160(5):2080-8. PubMed ID: 9498744
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ICOS-ligand, expressed on human endothelial cells, costimulates Th1 and Th2 cytokine secretion by memory CD4+ T cells.
    Khayyamian S; Hutloff A; Büchner K; Gräfe M; Henn V; Kroczek RA; Mages HW
    Proc Natl Acad Sci U S A; 2002 Apr; 99(9):6198-203. PubMed ID: 11983910
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of costimulators in T cell differentiation: studies using antigen-presenting cells lacking expression of CD80 or CD86.
    Schweitzer AN; Borriello F; Wong RC; Abbas AK; Sharpe AH
    J Immunol; 1997 Mar; 158(6):2713-22. PubMed ID: 9058805
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IL-4 treatment of small splenic B cells induces costimulatory molecules B7-1 and B7-2.
    Stack RM; Lenschow DJ; Gray GS; Bluestone JA; Fitch FW
    J Immunol; 1994 Jun; 152(12):5723-33. PubMed ID: 7515912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The differentiated state of intestinal lamina propria CD4+ T cells results in altered cytokine production, activation threshold, and costimulatory requirements.
    Hurst SD; Cooper CJ; Sitterding SM; Choi Jh; Jump RL; Levine AD; Barrett TA
    J Immunol; 1999 Dec; 163(11):5937-45. PubMed ID: 10570280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heterogeneous effects of B7-1 and B7-2 in the induction of both protective and therapeutic anti-tumor immunity against different mouse tumors.
    Martin-Fontecha A; Cavallo F; Bellone M; Heltai S; Iezzi G; Tornaghi P; Nabavi N; Forni G; Dellabona P; Casorati G
    Eur J Immunol; 1996 Aug; 26(8):1851-9. PubMed ID: 8765031
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Th1 development of naive CD4+ T cells is inhibited by co-activation with anti-CD4 monoclonal antibodies.
    Goedert S; Germann T; Hoehn P; Koelsch S; Palm N; Rüde E; Schmitt E
    J Immunol; 1996 Jul; 157(2):566-73. PubMed ID: 8752903
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monocyte-regulated IFN-gamma production in human T cells involves CD2 signaling.
    Wingren AG; Dahlenborg K; Björklund M; Hedlund G; Kalland T; Sjögren HO; Ljungdahl A; Olsson T; Ekre HP; Sansom D
    J Immunol; 1993 Aug; 151(3):1328-36. PubMed ID: 7687629
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD40 can costimulate human memory T cells and favors IL-10 secretion.
    Rogers NJ; Jackson IM; Jordan WJ; Lombardi G; Delikouras A; Lechler RI
    Eur J Immunol; 2003 Apr; 33(4):1094-104. PubMed ID: 12672076
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polarization of IL-4- and IFN-gamma-producing CD4+ T cells following activation of naive CD4+ T cells.
    Nakamura T; Kamogawa Y; Bottomly K; Flavell RA
    J Immunol; 1997 Feb; 158(3):1085-94. PubMed ID: 9013946
    [TBL] [Abstract][Full Text] [Related]  

  • 33. B7-2 requirement for helminth-induced granuloma formation and CD4 type 2 T helper cell cytokine expression.
    Subramanian G; Kazura JW; Pearlman E; Jia X; Malhotra I; King CL
    J Immunol; 1997 Jun; 158(12):5914-20. PubMed ID: 9190944
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of human T cell lymphotropic virus type I-infected T cells is independent of B7 costimulation.
    Scholz C; Freeman GJ; Greenfield EA; Hafler DA; Höllsberg P
    J Immunol; 1996 Oct; 157(7):2932-8. PubMed ID: 8816399
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutual regulation between B7-1 (CD80) expressed on T cells and IL-4.
    Schweitzer AN; Sharpe AH
    J Immunol; 1999 Nov; 163(9):4819-25. PubMed ID: 10528182
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of superantigen-induced T cell activation in the absence and the presence of MHC class II.
    Lando PA; Olsson C; Kalland T; Newton D; Kotb M; Dohlsten M
    J Immunol; 1996 Oct; 157(7):2857-63. PubMed ID: 8816390
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Costimulation with B7-1, IL-6, and IL-12 is sufficient for primary generation of murine antitumor cytolytic T lymphocytes in vitro.
    Gajewski TF; Renauld JC; Van Pel A; Boon T
    J Immunol; 1995 Jun; 154(11):5637-48. PubMed ID: 7538528
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human T helper cell differentiation is regulated by the combined action of cytokines and accessory cell-dependent costimulatory signals.
    Palmer EM; van Seventer GA
    J Immunol; 1997 Mar; 158(6):2654-62. PubMed ID: 9058798
    [TBL] [Abstract][Full Text] [Related]  

  • 39. B7 costimulation and autoantigen specificity enable B cells to activate autoreactive T cells.
    Roth R; Nakamura T; Mamula MJ
    J Immunol; 1996 Oct; 157(7):2924-31. PubMed ID: 8816398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. T-cell activation by recombinant receptors: CD28 costimulation is required for interleukin 2 secretion and receptor-mediated T-cell proliferation but does not affect receptor-mediated target cell lysis.
    Hombach A; Sent D; Schneider C; Heuser C; Koch D; Pohl C; Seliger B; Abken H
    Cancer Res; 2001 Mar; 61(5):1976-82. PubMed ID: 11280755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.